Li et al. indicated that KIF20A silencing significantly impaired the proliferative and invasive capabilities of ovarian cancer cells, and FOXO1 could target KIF20A to manipulate cellular behaviors (Li et al., 2020). The gene discussed is KIF20A; the disease is ovarian carcinoma.